Marshall Wace North America L.P. Purchases 46,740 Shares of Global Medical REIT Inc (NYSE:GMRE)

Marshall Wace North America L.P. boosted its position in Global Medical REIT Inc (NYSE:GMRE) by 74.4% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 109,538 shares of the company’s stock after acquiring an additional 46,740 shares during the period. Marshall Wace North America L.P. owned 0.30% of Global Medical REIT worth $1,449,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in GMRE. Stifel Financial Corp boosted its stake in shares of Global Medical REIT by 81.1% during the 3rd quarter. Stifel Financial Corp now owns 244,475 shares of the company’s stock valued at $2,793,000 after purchasing an additional 109,481 shares in the last quarter. Tower Research Capital LLC TRC boosted its stake in shares of Global Medical REIT by 186.6% during the 3rd quarter. Tower Research Capital LLC TRC now owns 4,443 shares of the company’s stock valued at $51,000 after purchasing an additional 2,893 shares in the last quarter. Swiss National Bank bought a new stake in shares of Global Medical REIT during the 4th quarter valued at about $1,031,000. Squarepoint Ops LLC boosted its stake in shares of Global Medical REIT by 69.5% during the 3rd quarter. Squarepoint Ops LLC now owns 81,349 shares of the company’s stock valued at $927,000 after purchasing an additional 33,357 shares in the last quarter. Finally, State Street Corp boosted its stake in shares of Global Medical REIT by 11.8% during the 3rd quarter. State Street Corp now owns 714,435 shares of the company’s stock valued at $8,284,000 after purchasing an additional 75,168 shares in the last quarter. 58.21% of the stock is currently owned by institutional investors and hedge funds.

GMRE has been the topic of a number of research reports. B. Riley raised shares of Global Medical REIT from a “neutral” rating to a “buy” rating and cut their target price for the company from $16.00 to $12.00 in a research note on Wednesday, March 18th. Janney Montgomery Scott raised shares of Global Medical REIT from a “neutral” rating to a “buy” rating and set a $14.50 target price on the stock in a research note on Tuesday, January 7th. Zacks Investment Research lowered shares of Global Medical REIT from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, March 10th. Robert W. Baird lifted their price target on shares of Global Medical REIT from $14.00 to $17.00 and gave the company an “outperform” rating in a research report on Friday, March 6th. Finally, Stifel Nicolaus lifted their price target on shares of Global Medical REIT from $14.00 to $16.00 and gave the company a “buy” rating in a research report on Thursday, March 5th. Two analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus target price of $14.79.

Shares of NYSE GMRE opened at $10.17 on Thursday. Global Medical REIT Inc has a 1 year low of $6.98 and a 1 year high of $15.95. The stock has a market cap of $428.88 million, a P/E ratio of 12.92 and a beta of 0.45. The firm has a 50-day moving average of $13.51 and a 200 day moving average of $12.93. The company has a debt-to-equity ratio of 0.92, a current ratio of 0.16 and a quick ratio of 0.16.

Global Medical REIT (NYSE:GMRE) last issued its quarterly earnings results on Wednesday, March 4th. The company reported $0.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.20 by ($0.17). Global Medical REIT had a net margin of 11.12% and a return on equity of 2.49%. The business had revenue of $20.45 million for the quarter, compared to analysts’ expectations of $19.44 million. Research analysts expect that Global Medical REIT Inc will post 0.84 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Thursday, April 9th. Investors of record on Wednesday, March 25th will be given a dividend of $0.20 per share. The ex-dividend date of this dividend is Tuesday, March 24th. This represents a $0.80 dividend on an annualized basis and a yield of 7.87%. Global Medical REIT’s dividend payout ratio (DPR) is currently 106.67%.

Global Medical REIT Company Profile

Global Medical REIT, Inc engages in the acquisition of purpose-built healthcare facilities and leasing of those properties to strong healthcare systems and physician groups. The company was founded on March 18, 2011 and is headquartered in Bethesda, MD.

Read More: Stocks Increasing Dividends

Want to see what other hedge funds are holding GMRE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Global Medical REIT Inc (NYSE:GMRE).

Institutional Ownership by Quarter for Global Medical REIT (NYSE:GMRE)

Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.